T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Vornado Realty Trust
VNO
$7.24B
| $436M | 0.09% |
5,583,556
-1,032,867
| -16% | -$78.4M |
|
|
CLGX
252
DELISTED
Corelogic, Inc.
CLGX
| $436M | 0.09% |
14,347,654
-310,864
| -2% | -$8.98M |
|
253
Capri Holdings
CPRI
$1.77B
| $435M | 0.09% |
4,903,805
+951,064
| +24% | +$87.4M |
|
|
FEIC
254
DELISTED
FEI COMPANY
FEIC
| $434M | 0.09% |
4,786,554
+1,134,152
| +31% | +$99.9M |
|
255
Pacira BioSciences
PCRX
$972M
| $434M | 0.09% |
4,726,726
+79,630
| +2% | +$6.06M |
|
256
JB Hunt Transport Services
JBHT
$24.9B
| $432M | 0.09% |
5,858,379
+4,309
| +0.1% | +$327K |
|
257
Perrigo
PRGO
$1.78B
| $428M | 0.09% |
2,937,995
+951,461
| +48% | +$135M |
|
258
Campbell Soup
CPB
$6.78B
| $427M | 0.09% |
9,318,528
-12,200
| -0.1% | -$551K |
|
|
CVD
259
DELISTED
COVANCE INC.
CVD
| $427M | 0.09% |
4,987,709
-493,006
| -9% | -$43.9M |
|
260
Archrock
AROC
$5.78B
| $426M | 0.09% |
9,476,044
-1,631,682
| -15% | -$70.5M |
|
261
Macy's
M
$6.45B
| $426M | 0.09% |
7,337,771
-26,130
| -0.4% | -$1.52M |
|
262
Equifax
EFX
$21.4B
| $425M | 0.09% |
5,853,671
-44,711
| -0.8% | -$3.14M |
|
|
DFS
263
DELISTED
Discover Financial Services
DFS
| $421M | 0.09% |
6,798,090
+3,030,254
| +80% | +$177M |
|
|
WWAV
264
DELISTED
The WhiteWave Foods Company
WWAV
| $420M | 0.09% |
12,979,031
-2,831,200
| -18% | -$84.7M |
|
265
Oracle
ORCL
$419B
| $419M | 0.09% |
10,334,953
-2,862,290
| -22% | -$118M |
|
|
WPX
266
DELISTED
WPX Energy, Inc.
WPX
| $417M | 0.09% |
17,458,907
+838,974
| +5% | +$17.8M |
|
|
POT
267
DELISTED
Potash Corp Of Saskatchewan
POT
| $414M | 0.09% |
10,910,677
+823,824
| +8% | +$29.7M |
|
268
LyondellBasell Industries
LYB
$20.7B
| $413M | 0.09% |
4,233,496
-10,697
| -0.3% | -$1.02M |
|
|
CLR
269
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $413M | 0.09% |
5,223,130
+3,825,168
| +274% | +$266M |
|
270
Quest Diagnostics
DGX
$26.2B
| $412M | 0.09% |
7,022,359
-910,131
| -11% | -$53.3M |
|
271
Flowers Foods
FLO
$1.52B
| $408M | 0.09% |
19,337,529
+1,760,249
| +10% | +$36.4M |
|
|
TLM
272
DELISTED
TALISMAN ENERGY INC
TLM
| $408M | 0.09% |
38,476,892
-6,409,891
| -14% | -$66.9M |
|
|
THS
273
DELISTED
Treehouse Foods
THS
| $407M | 0.09% |
5,084,173
+330
| +0% | +$24.6K |
|
274
Analog Devices
ADI
$188B
| $405M | 0.09% |
7,484,780
-104,074
| -1% | -$5.51M |
|
275
W.W. Grainger
GWW
$61.3B
| $405M | 0.09% |
1,591,097
+548,529
| +53% | +$140M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.